Chemed Inc (CHE) 132.09 $CHE
Chemed Corporation Announces the Retirement of Timothy S. O'Toole
BusinessWire - Wed Jun 08, 4:00PM CDT
After more than a decade of leading VITAS Healthcare Corporation to become the single largest hospice provider in America, Chief Executive Officer Timothy S. O'Toole has decided to retire. He will, however, stay on to help the company in a consulting capacity.
CHE: 132.09 (-1.78)
Chemed Posts Balanced Growth amid Coding Change Issues
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 5:42AM CDT
On Jun 7, 2016, we issued an updated research report on Chemed Corporation (CHE).
CHE: 132.09 (-1.78), PMC: 26.43 (-0.66), LHCG: 42.75 (-0.78), HLS: 40.54 (-1.02)
Chemed Corporation to Present at the Jefferies 2016 Global Healthcare Conference
BusinessWire - Tue May 31, 1:31PM CDT
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Jefferies 2016 Global Healthcare Conference on Tuesday, June 7, 2016, at approximately 4:00 p.m. (ET) in New York City.
CHE: 132.09 (-1.78)
Chemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly Dividend
BusinessWire - Mon May 16, 1:59PM CDT
Shareholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2016 annual shareholders' meeting. Each of the directors continues from the prior term.
CHE: 132.09 (-1.78)
Chemed Corporation to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
BusinessWire - Thu May 05, 1:39PM CDT
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2016 Health Care Conference on Wednesday, May 11, 2016, at 9:20 AM (PDT) at the Encore at the Wynn Las Vegas.
CHE: 132.09 (-1.78)
Chemed (CHE) Q1 Earnings Miss the Mark, Revenues in Line
Zacks Equity Research - Zacks Investment Research - Mon May 02, 9:53AM CDT
Chemed Corp. (CHE) reported first-quarter 2016 adjusted earnings per share (EPS) of $1.53.
CHE: 132.09 (-1.78), AFAM: 42.11 (-0.81), AMED: 51.80 (-1.00), HLS: 40.54 (-1.02)
Chemed posts 1Q profit
Automated Insights - Thu Apr 28, 5:53PM CDT
CINCINNATI (AP) _ Chemed Corp. (CHE) on Thursday reported first-quarter earnings of $24.8 million.
CHE: 132.09 (-1.78)
Chemed Reports First-Quarter 2016 Results
BusinessWire - Thu Apr 28, 3:15PM CDT
Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2016, versus the comparable prior-year period, as follows:
CHE: 132.09 (-1.78)
Chemed To Report First-Quarter 2016 Earnings April 28, Related Conference Call To Be Held On April 29
BusinessWire - Fri Apr 15, 2:18PM CDT
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2016, on Thursday, April 28, 2016, following the close of trading on the New York Stock Exchange.
CHE: 132.09 (-1.78)
Chemed Corporation's Board of Directors Authorizes an Additional $100 Million for Stock Repurchase
BusinessWire - Mon Mar 14, 7:00AM CDT
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $100 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.
CHE: 132.09 (-1.78)
Chemed (CHE): Moving Average Crossover Alert
Zacks Equity Research - Zacks Investment Research - Fri Mar 04, 9:56AM CST
Chemed Corp. (CHE) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
CHE: 132.09 (-1.78)
Chemed Corporation Declares Quarterly Dividend of 24 Cents
BusinessWire - Fri Feb 19, 11:41AM CST
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 24-cents per share on the Company's capital stock, payable on March 21, 2016, to shareholders of record as of February 29, 2016. This represents the 179th consecutive quarterly dividend paid by Chemed in its 44 years as a public company.
CHE: 132.09 (-1.78)
Chemed Beats Q4 Earnings, Revenues; Cash Balance Strong
Zacks Equity Research - Zacks Investment Research - Thu Feb 18, 11:10AM CST
Chemed (CHE) ended 2015 on an impressive note, with its fourth-quarter results exceeding the Zacks Consensus Estimate of earnings and revenues.
CHE: 132.09 (-1.78), VASC: 39.58 (-0.56), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Chemed To Report Fourth-Quarter 2015 Earnings February 17, Related Conference Call To Be Held On February 18
BusinessWire - Thu Feb 04, 1:40PM CST
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2015, on Wednesday, February 17, 2016, following the close of trading on the New York Stock Exchange.
CHE: 132.09 (-1.78)
Chemed Corporation to Present at the 34th Annual J.P. Morgan Healthcare Conference
BusinessWire - Thu Jan 07, 12:52PM CST
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 34th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2016, at approximately 11:30 a.m. PST at the Westin St. Francis Hotel in San Francisco, CA.
CHE: 132.09 (-1.78), JPM: 63.84 (-0.91)
Chemed (CHE) Impresses in Q3 despite Coding Change Issues
Zacks Equity Research - Zacks Investment Research - Thu Dec 24, 1:10PM CST
On Dec 24, 2015, we issued an updated research report on Chemed Corporation (CHE).
CHE: 132.09 (-1.78), AMSG: 80.11 (-0.89), PMC: 26.43 (-0.66), AMED: 51.80 (-1.00)
Amedisys: Balanced Growth on Strategic Buyouts, Demography
Zacks Equity Research - Zacks Investment Research - Wed Dec 16, 1:15PM CST
On Dec 14, 2015, we issued an updated research report on Amedisys Inc. (AMED), a provider of home health and hospice services across the U.S.
CHE: 132.09 (-1.78), AMSG: 80.11 (-0.89), PMC: 26.43 (-0.66), AMED: 51.80 (-1.00)
Chemed (CHE) Poised on Balanced Growth, Solid Fundamentals
Zacks Equity Research - Zacks Investment Research - Fri Nov 27, 12:30PM CST
On Nov 26, 2015, we initiated our coverage on Chemed Corporation (CHE).
CHE: 132.09 (-1.78), AMSG: 80.11 (-0.89), LHCG: 42.75 (-0.78)
Chemed's board sets 178th consecutive quarterly dividend payment date of 7 December 2015
M2 - Mon Nov 09, 4:16AM CST
The board of directors Chemed Corporation (NYSE:CHE) on Friday declared a quarterly dividend of USD0.24 per share on the company's capital stock.
CHE: 132.09 (-1.78)
Chemed Corporation Announces the Retirement of Timothy S. O'Toole
BusinessWire - Wed Jun 08, 4:00PM CDT
After more than a decade of leading VITAS Healthcare Corporation to become the single largest hospice provider in America, Chief Executive Officer Timothy S. O'Toole has decided to retire. He will, however, stay on to help the company in a consulting capacity.
CHE: 132.09 (-1.78)
Chemed Posts Balanced Growth amid Coding Change Issues
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 5:42AM CDT
On Jun 7, 2016, we issued an updated research report on Chemed Corporation (CHE).
CHE: 132.09 (-1.78), PMC: 26.43 (-0.66), LHCG: 42.75 (-0.78), HLS: 40.54 (-1.02)
Chemed Corporation to Present at the Jefferies 2016 Global Healthcare Conference
BusinessWire - Tue May 31, 1:31PM CDT
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Jefferies 2016 Global Healthcare Conference on Tuesday, June 7, 2016, at approximately 4:00 p.m. (ET) in New York City.
CHE: 132.09 (-1.78)
Chemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly Dividend
BusinessWire - Mon May 16, 1:59PM CDT
Shareholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2016 annual shareholders' meeting. Each of the directors continues from the prior term.
CHE: 132.09 (-1.78)
Chemed Corporation to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
BusinessWire - Thu May 05, 1:39PM CDT
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2016 Health Care Conference on Wednesday, May 11, 2016, at 9:20 AM (PDT) at the Encore at the Wynn Las Vegas.
CHE: 132.09 (-1.78)
Chemed (CHE) Q1 Earnings Miss the Mark, Revenues in Line
Zacks Equity Research - Zacks Investment Research - Mon May 02, 9:53AM CDT
Chemed Corp. (CHE) reported first-quarter 2016 adjusted earnings per share (EPS) of $1.53.
CHE: 132.09 (-1.78), AFAM: 42.11 (-0.81), AMED: 51.80 (-1.00), HLS: 40.54 (-1.02)
Chemed posts 1Q profit
Automated Insights - Thu Apr 28, 5:53PM CDT
CINCINNATI (AP) _ Chemed Corp. (CHE) on Thursday reported first-quarter earnings of $24.8 million.
CHE: 132.09 (-1.78)
Chemed Reports First-Quarter 2016 Results
BusinessWire - Thu Apr 28, 3:15PM CDT
Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2016, versus the comparable prior-year period, as follows:
CHE: 132.09 (-1.78)
Chemed To Report First-Quarter 2016 Earnings April 28, Related Conference Call To Be Held On April 29
BusinessWire - Fri Apr 15, 2:18PM CDT
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2016, on Thursday, April 28, 2016, following the close of trading on the New York Stock Exchange.
CHE: 132.09 (-1.78)
Chemed Corporation's Board of Directors Authorizes an Additional $100 Million for Stock Repurchase
BusinessWire - Mon Mar 14, 7:00AM CDT
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $100 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.
CHE: 132.09 (-1.78)
Chemed (CHE): Moving Average Crossover Alert
Zacks Equity Research - Zacks Investment Research - Fri Mar 04, 9:56AM CST
Chemed Corp. (CHE) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
CHE: 132.09 (-1.78)
Chemed Corporation Declares Quarterly Dividend of 24 Cents
BusinessWire - Fri Feb 19, 11:41AM CST
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 24-cents per share on the Company's capital stock, payable on March 21, 2016, to shareholders of record as of February 29, 2016. This represents the 179th consecutive quarterly dividend paid by Chemed in its 44 years as a public company.
CHE: 132.09 (-1.78)
Chemed Beats Q4 Earnings, Revenues; Cash Balance Strong
Zacks Equity Research - Zacks Investment Research - Thu Feb 18, 11:10AM CST
Chemed (CHE) ended 2015 on an impressive note, with its fourth-quarter results exceeding the Zacks Consensus Estimate of earnings and revenues.
CHE: 132.09 (-1.78), VASC: 39.58 (-0.56), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)
Chemed To Report Fourth-Quarter 2015 Earnings February 17, Related Conference Call To Be Held On February 18
BusinessWire - Thu Feb 04, 1:40PM CST
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2015, on Wednesday, February 17, 2016, following the close of trading on the New York Stock Exchange.
CHE: 132.09 (-1.78)
Chemed Corporation to Present at the 34th Annual J.P. Morgan Healthcare Conference
BusinessWire - Thu Jan 07, 12:52PM CST
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 34th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2016, at approximately 11:30 a.m. PST at the Westin St. Francis Hotel in San Francisco, CA.
CHE: 132.09 (-1.78), JPM: 63.84 (-0.91)
Chemed (CHE) Impresses in Q3 despite Coding Change Issues
Zacks Equity Research - Zacks Investment Research - Thu Dec 24, 1:10PM CST
On Dec 24, 2015, we issued an updated research report on Chemed Corporation (CHE).
CHE: 132.09 (-1.78), AMSG: 80.11 (-0.89), PMC: 26.43 (-0.66), AMED: 51.80 (-1.00)
Amedisys: Balanced Growth on Strategic Buyouts, Demography
Zacks Equity Research - Zacks Investment Research - Wed Dec 16, 1:15PM CST
On Dec 14, 2015, we issued an updated research report on Amedisys Inc. (AMED), a provider of home health and hospice services across the U.S.
CHE: 132.09 (-1.78), AMSG: 80.11 (-0.89), PMC: 26.43 (-0.66), AMED: 51.80 (-1.00)
Chemed (CHE) Poised on Balanced Growth, Solid Fundamentals
Zacks Equity Research - Zacks Investment Research - Fri Nov 27, 12:30PM CST
On Nov 26, 2015, we initiated our coverage on Chemed Corporation (CHE).
CHE: 132.09 (-1.78), AMSG: 80.11 (-0.89), LHCG: 42.75 (-0.78)
Chemed's board sets 178th consecutive quarterly dividend payment date of 7 December 2015
M2 - Mon Nov 09, 4:16AM CST
The board of directors Chemed Corporation (NYSE:CHE) on Friday declared a quarterly dividend of USD0.24 per share on the company's capital stock.
CHE: 132.09 (-1.78)
